Streetbeat News

Equity Actions

JELD

Jeld-Wen Holding Inc. has filed for a mixed shelf offering with the SEC, though the size of the offering has not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 8:16 pm

ICG

Intchains Group has filed for a mixed shelf offering of up to $300 million. This move allows the company to issue various types of securities, including common stock, preferred stock, debt securities, and warrants, over time.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 8:15 pm

TGAA

Target Global Acquisition announced that CEO Shmuel Chafets has resigned but will remain as a director. Chief Investment Officer Yaron Valler has also resigned. Michael Minnick has been appointed as the new CEO effective immediately.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 8:14 pm

PINE

Alpine Income Property Trust has appointed Philip R. Mays as Senior Vice President, Chief Financial Officer, and Treasurer, effective June 17, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 8:12 pm

TIPT

Tiptree Inc. has filed a $500 million mixed-securities shelf registration, allowing the company to issue various types of securities over time. This move provides Tiptree with the flexibility to raise capital as needed.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 8:07 pm

LPTV

Loop Media shares are trading lower following the announcement of a $2.45 million registered direct offering and private placement.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 6:38 pm

AMBA

CLDI

DELL

GPS

MDB

NVOS

U.S. stocks traded mixed with the Dow Jones gaining 250 points, while the NASDAQ and S&P 500 fell. MongoDB shares plummeted 25% due to weak FY25 guidance, while Ambarella, The Gap, and Novo Integrated Sciences saw significant gains. Dell and Calidi Biotherapeutics shares also dropped.

Portfolio Pulse from Avi Kapoor

May 31, 2024 | 6:37 pm

LFMD

LifeMD has filed a prospectus related to the resale of up to 1.3 million shares of common stock held by selling stockholders, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 6:31 pm

CLDI

Calidi Biotherapeutics Inc (NASDAQ:CLDI) shares dropped by 30.7% to $0.21 after announcing a definitive agreement for the immediate exercise of Series B and C warrants to buy up to 10.698 million shares at 20 cents per share. This move is expected to generate approximately $2.1 million before fees and expenses. New unregistered warrants and Series B-1 and C-1 warrants will also be issued. The proceeds will fund clinical and pre-clinical programs, operating expenses, and working capital.

Portfolio Pulse from Henry Khederian

May 31, 2024 | 5:36 pm

CLDI

Calidi Biotherapeutics shares are trading lower after the company announced the exercise of warrants for $2.1 million in gross proceeds.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 5:36 pm